Disassembly of Amyloid Fibrils by Premicellar and Micellar Aggregates of a Tetrameric Cationic Surfactant in Aqueous Solution-Reference-Cited by-同舟云学术

Disassembly of Amyloid Fibrils by Premicellar and Micellar Aggregates of a Tetrameric Cationic Surfactant in Aqueous Solution

Published:2011-03-25 Issue:8 Volume:27 Page:4551-4556
ISSN:0743-7463
Container-title:Langmuir
language:en
Short-container-title:Langmuir

Author:

He Chengqian¹,Hou Yanbo¹,Han Yuchun¹,Wang Yilin¹

Affiliation:

1. Key Laboratory of Colloid and Interface Science, Beijing National Laboratory for Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, People’s Republic of China

Publisher

American Chemical Society (ACS)

Subject

Electrochemistry,Spectroscopy,Surfaces and Interfaces,Condensed Matter Physics,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/la200350j

Reference24 articles.

1. Amyloid deposition as the central event in the aetiology of Alzheimer's disease

2. β-Amyloid therapies in Alzheimer’s disease

3. Characterizing the Appearance and Growth of Amyloid Plaques in APP/PS1 Mice

4. A Caenorhabditis elegans model of tau hyperphosphorylation: Induction of developmental defects by transgenic overexpression of Alzheimer's disease-like modified tau

5. Alzheimer's disease

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitoring the interactions between POPG phospholipid bilayer and amyloid-forming protein human cystatin C. Does the bilayer influence the oligomeric state and structure of the protein?;Biochimica et Biophysica Acta (BBA) - Biomembranes;2024-03

2. Amyloid Disassembly: What Can We Learn from Chaperones?;Biomedicines;2022-12-17

3. Moxifloxacin Disrupts and Attenuates A?42 Fibril and Oligomer Formation: Plausibly Repositioning an Antibiotic as Therapeutic against Alzheimer?s Disease;ACS CHEM NEUROSCI;2022

4. Moxifloxacin Disrupts and Attenuates Aβ42 Fibril and Oligomer Formation: Plausibly Repositioning an Antibiotic as Therapeutic against Alzheimer’s Disease;ACS Chemical Neuroscience;2022-08-05

5. Peptide-Modified Gemini Surfactants as Delivery System Building Blocks with Dual Functionalities for Glaucoma Treatment: Gene Carriers and Amyloid-Beta (Aβ) Self-Aggregation Inhibitors;Molecular Pharmaceutics;2022-07-08